Cartesian Therapeutics, Inc. (RNAC) Earnings
NASDAQ·Healthcare·Biotechnology
$6.45
+2.63%
Mkt Cap $299.10M
EPS — Estimate vs Actual
Mkt Cap
$299.10M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02
NASDAQ·Healthcare·Biotechnology
$6.45
+2.63%
Mkt Cap $299.10M
Mkt Cap
$299.10M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02